Eterna Therapeutics
ERNA
#11147
Rank
โ‚น0.30 B
Marketcap
โ‚น187.05
Share price
-6.64%
Change (1 day)
18.56%
Change (1 year)

EPS for Eterna Therapeutics (ERNA)

EPS in 2026 (TTM): -โ‚น2,608

According to Eterna Therapeutics's latest financial reports the company's current EPS (TTM) is -โ‚น2,781. In 2022 the company made an earnings per share (EPS) of -โ‚น2,98,736 an increase over its 2021 EPS that were of -โ‚น19,73,654.

EPS history for Eterna Therapeutics from 2021 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น2,608
2022-โ‚น2,98,736-84.86%
2021-โ‚น19,73,654

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
โ‚น180.68-106.50%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
-โ‚น196.55-92.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Omeros Corporation
OMER
โ‚น162.36-105.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
-โ‚น10.44-99.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Genetic Technologies
GENE
N/AN/A๐Ÿ‡ฆ๐Ÿ‡บ Australia
Teva Pharmaceutical Industries
TEVA
โ‚น59.82-102.15%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Bio-Techne
TECH
โ‚น111.09-103.99%๐Ÿ‡บ๐Ÿ‡ธ USA